Rowe Brian H, Villa-Roel Cristina, Guttman Alex, Ross Scott, Mackey Duncan, Sivilotti Marco L A, Worster Andrew, Stiell Ian G, Willis Virginia, Borgundvaag Bjug
Department of Emergency Medicine, University of Alberta, Edmonton, Alberta, Canada.
Acad Emerg Med. 2009 Apr;16(4):316-24. doi: 10.1111/j.1553-2712.2009.00366.x. Epub 2009 Mar 6.
The objective was to examine predictors of hospital admission among adults presenting to Canadian emergency departments (EDs) for acute exacerbations of chronic obstructive pulmonary disease (COPD). Current acute treatment approaches and outcomes 2 weeks after the ED visit are also described.
Subjects, aged > or =35 years presenting with COPD exacerbations to 16 EDs across Canada, underwent a structured in-ED interview and a telephone interview 2 weeks later.
Of 501 study patients, 247 (49.3%; 95% confidence interval [CI] = 44.9% to 53.6%) were admitted. Admitted patients were older, were more often former smokers, and had more admissions for COPD during the past 2 years. They also reported more days of activity limitation and use of inhaled beta(2)-agonists in the previous 24 hours. Canadian Triage and Acuity Scale (CTAS), respiratory rate (RR), and airflow obstruction were more severe in the hospitalized group. Most of the patients received inhaled beta(2)-agonists, anticholinergics, oral corticosteroids (CS), and antibiotics; hospitalized patients received more aggressive treatments. The median ED length of stay (LOS) of admitted patients was 13.1 hours (interquartile range [IQR] = 7.4-23.0) compared to 5.6 hours (IQR = 4.2-8.4) in discharged patients. Admission was associated with at least two COPD admissions in the past 2 years (odds ratio [OR] = 2.10; 95% CI = 1.24 to 3.56), receiving oral CS for COPD (OR = 1.72; 95% CI = 1.08 to 2.74), having a CTAS score of 1-2 (OR = 2.04; 95% CI = 1.33 to 3.12), and receiving adjunct ED treatments (OR = 3.95; 95% CI = 2.45 to 6.35). Use of EDs for usual COPD care was associated with a reduced risk of admission (OR = 0.43; 95% CI = 0.28 to 0.66).
Exacerbations of COPD in Canadian EDs result in prolonged ED stays and approximately 50% hospitalization despite aggressive acute treatment approaches. Historical, severity, and treatment-related factors were strongly associated with hospital admission. Validation of these results should be completed prior to widespread use.
本研究旨在探讨因慢性阻塞性肺疾病(COPD)急性加重而前往加拿大急诊科(ED)就诊的成年人住院的预测因素。同时还描述了当前的急性治疗方法以及急诊就诊2周后的治疗结果。
年龄≥35岁、因COPD加重前往加拿大16家急诊科就诊的患者,在急诊科接受了结构化访谈,并在2周后接受了电话访谈。
501名研究患者中,247人(49.3%;95%置信区间[CI]=44.9%至53.6%)被收治入院。入院患者年龄更大,更常为既往吸烟者,且在过去2年中因COPD入院次数更多。他们还报告在过去24小时内活动受限天数更多,且使用吸入性β2受体激动剂的频率更高。加拿大分诊和 acuity 量表(CTAS)评分、呼吸频率(RR)以及气流阻塞情况在住院组更为严重。大多数患者接受了吸入性β2受体激动剂、抗胆碱能药物、口服糖皮质激素(CS)和抗生素治疗;住院患者接受的治疗更为积极。入院患者在急诊科的中位住院时间(LOS)为13.1小时(四分位间距[IQR]=7.4 - 23.0),而出院患者为5.6小时(IQR = 4.2 - 8.4)。住院与过去2年中至少两次因COPD入院(比值比[OR]=2.10;95%CI = 1.24至3.56)、因COPD接受口服CS治疗(OR = 1.72;95%CI = 1.08至2.74)、CTAS评分为1 - 2分(OR = 2.04;95%CI = 1.33至3.12)以及接受急诊科辅助治疗(OR = 3.95;95%CI = 2.45至6.35)相关。将急诊科用于COPD常规治疗与入院风险降低相关(OR = 0.43;95%CI = 0.28至0.66)。
尽管采用了积极的急性治疗方法,但加拿大急诊科的COPD加重仍导致急诊科住院时间延长,且约50%的患者住院。既往史、严重程度和治疗相关因素与住院密切相关。在广泛应用之前,应完成这些结果的验证。